Albert Vallejo-Gracia

Albert Vallejo-Gracia has a strong background in biomedicine and biochemistry, with experience ranging from teaching assistant to postdoctoral research roles. Albert has conducted research on various topics, including HIV latency, SARS-CoV-2 biology, and ion channel expression in cancer. Currently working as a Scientist III at T-knife Therapeutics, focusing on analytical development in the CMC Department, Albert excels in assay development, project management, and tech transfer. Albert's passion for cutting-edge science and transformative research has been evident throughout their career.